本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Assembly Biosciences Inc.

29.80
-0.6600-2.17%
盤後29.800.00000.00%19:30 EDT
成交量:25.89萬
成交額:779.56萬
市值:6.07億
市盈率:-1.16萬
高:31.72
開:30.83
低:29.68
收:30.46
52周最高:39.71
52周最低:20.23
股本:2,036.06萬
流通股本:917.37萬
量比:0.77
換手率:2.82%
股息:- -
股息率:- -
每股收益(TTM):-0.0026
每股收益(LYR):-0.5461
淨資產收益率:-0.03%
總資產收益率:-2.67%
市淨率:1.99
市盈率(LYR):-54.57

資料載入中...

2023/11/22

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/03

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/26

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/10/17

重要事件披露

Form 8-K - Current report
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/29

重要事件披露

Form 8-K - Current report
2023/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

重要事件披露

Form 8-K - Current report
2023/08/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/30

重要事件披露

Form 8-K - Current report
2023/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities